
Castle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting
Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests…












